肺癌患者术后医院感染临床分析及头孢噻肟的预防疗效

Clinical analysis of postoperative nosocomial infection of patients with lung cancer and the prevention effect of cefotaxime

  • 摘要: 目的 探讨肺癌患者术后发生院内肺部感染的临床特点及头孢噻肟的预防疗效。方法 收集2014年5月-2016年10月在医院胸外科住院并行手术治疗的160例肺癌患者的临床资料。统计患者术后医院肺部感染发生率,单因素及多因素Logistic回归分析感染的影响因素。行肺癌根治术的患者中,80例围术期给予头孢噻肟2 g静脉滴注,80例围术期给予头孢噻肟4 g静脉滴注,比较两组术后肺部感染率及术前术后血中血红蛋白、白蛋白水平及白细胞计数。结果 160例初次进行手术的肺癌患者,术后发生医院肺部感染47例,感染率为29.38%;多因素Logistic分析结果显示,高龄、糖尿病史、COPD、吸烟史、抑酸剂使用时间、手术时间、机械通气时间、切口疼痛明显为肺癌患者术后医院肺部感染的影响因素(P<0.05);术后,两组血红蛋白、白蛋白水平均低于术前,白细胞计数均高于术前(P<0.001);且头孢噻肟4 g组血红蛋白、白蛋白水平高于头孢噻肟2 g组,白细胞计数低于头孢噻肟2 g组(P<0.001)。结论 肺癌患者术后医院肺部感染的影响因素较多,应针对性地给予预防措施,围术期给予小剂量头孢噻肟对预防术后感染有一定效果。

     

    Abstract: OBJECTIVE To explore the clinical analysis of postoperative nosocomial infection of patients with lung cancer and the prevention effect of cefotaxime. METHODS The clinical data of 160 patients with lung cancer admitted and treated in the department of thoracic surgery from May 2014 to Oct. 2016 were collected. The incidence of postoperative nosocomial pulmonary infection was statistically analyzed. Univariate analysis and multivariate logistic regression analysis were performed to analyze the risk factors of infection. In the patients undergoing radical resection of lung cancer, 80 cases of patients were given 2 g of cefotaxime via intravenous drip in the perioperative period, and the rest 80 patients were given 4 g of cefotaxime via intravenous drip in the perioperative period. The postoperative pulmonary infection rate as well as the postoperative and preoperative hemoglobin, albumin levels in the blood and WBC count were compared between the two groups. RESULTS Of the 160 patients with lung cancer undergoing first operation, 47 cases of postoperative nosocomial pulmonary infection occurred, and the infection rate was 29.38%. Multivariate logistic regression analysis results showed that old age, diabetes history, COPD, smoking history, use time of acid-inhibiting agent, operation time, mechanical ventilation time, obvious incision pain were independent risk factors for postoperative nosocomial lung infection in lung cancer patients (P<0.05). The postoperative levels of hemoglobin and albumin in two groups were significantly lower than before the operation, and the WBC counts were significantly higher than before the operation (P<0.001). The blood hemoglobin and albumin levels in the 4 g cefotaxime group were significantly higher than those of the 2 g cefotaxime group, and the WBC count in the 4 g cefotaxime group was significantly lower than that in the 2 g cefotaxime group (P<0.001). CONCLUSION There are a number of risk factors for postoperative nosocomial lung infection in patients with lung cancer. Prevention measures should be taken accordingly. Administration of small dose of cefotaxime during the perioperative period is effective in preventing postoperative infection.

     

/

返回文章
返回